Jason Haas Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Jason Haas is Chief Financial Officer of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 124,552 shares of SYRS, which is worth approximately $265,295. The most recent transaction as insider was on Sep 12, 2024, when has been sold 45,344 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $76,177. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
407.3% 3M change
792.78% 12M change
Total Value Held $265,295

Jason Haas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2024
BUY
Open market or private purchase
$76,177 $1.68 p/Share
45,344 Added 26.69%
124,552 Common Stock
Sep 11 2024
BUY
Open market or private purchase
$30,482 $1.58 p/Share
19,293 Added 19.59%
79,208 Common Stock
Sep 10 2024
BUY
Open market or private purchase
$54,812 $1.55 p/Share
35,363 Added 37.12%
59,915 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$24,227 $5.12 p/Share
4,732 Reduced 16.16%
24,552 Common Stock
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
15,333 Added 34.37%
29,284 Common Stock
Nov 01 2023
SELL
Payment of exercise price or tax liability
$13,988 $2.22 p/Share
6,301 Reduced 31.11%
13,951 Common Stock
Oct 31 2023
BUY
Exercise of conversion of derivative security
-
18,875 Added 48.24%
20,252 Common Stock
Apr 03 2023
SELL
Payment of exercise price or tax liability
$1,607 $2.58 p/Share
623 Reduced 31.15%
1,377 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 50.0%
2,000 Common Stock

Also insider at

LGND
LIGAND PHARMACEUTICALS INC Healthcare
Director
JH

Jason Haas

Chief Financial Officer
Emeryville, CA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS